Medication Guidance-Metered-Dose Inhaler 用藥指導-定量噴霧吸入劑
2023/2/21Metered-dose inhalers should be tested in the air to determine whether they can be used before the first use or when not in use for several days, depending on the item.
Medication Guidance-Inhaled Chronic Obstructive Pulmonary Disease Drugs 用藥指導-吸入劑型之慢性阻塞性肺病藥品有哪些？
2023/2/21refers to drugs that can reduce inflammation of bronchial mucosa, including steroids, leukotriene receptor antagonists, sustained-release theophylline agents, and long-acting β2-agonists.
Medication Guidance-Klean-Prep Powder 用藥指導-Klean-Prep powder(刻見清)粉劑
2023/2/21Before use, pour Klean-Prep powder into 1,000 c.c. cold boiled water and stir until the powder is completely dissolved to form a solution.
Medication Guidance-K-Citrate 用藥指導-K-Citrate(結石清)
2023/2/21Usually, adults can take it three or four times a day after meals or before bed. The doctor will adjust the dosage according to your urine analysis and evaluation.
Medication Guidance-Differin 用藥指導-Differin(痘膚潤)
2023/2/21Apply it once a day to the affected part of the acne. Apply a layer of gel film and carefully avoid the eyes, lips and nose corner.
Medication Guidance-Anti-inflammatory Throat Spray 用藥指導-口腔消炎噴液劑
2023/2/21Adults (>12 years): Directly spray it 2-4 times on sore and swollen areas before slowly swallowing. Children aged 6-12 years: Directly spray it twice over sore and swollen areas before slowly swallowing. It can be reused every 1.5 to 3 hours if necessary.
Medication Guidance-Xenical Capsules 用藥指導-Xenical(羅鮮子)膠囊
2023/2/21It is recommended that one capsule be taken orally during the main meal or within 1 hour at the latest after the meal.
Medication Guidance-Metered-dose, Dry Powder Inhaler Accuhaler 用藥指導-定量粉狀吸入劑Accuhaler(胖胖魚)
2023/2/21The use of the metered-dose, dry powder inhaler Accuhaler is completely controlled by the patient's breathing.
Patient Safety: General Medication Safety Instructions 病人安全 一般用藥安全須知
2023/2/21Allergic or abnormal reactions to medicines, foods or special substances.
Medication Instruction- Oral Antiviral Drug(Molnupiravir) for COVID-19 用藥指導-COVID-19治療口服抗病毒藥品Molnupiravir
2023/2/21Applicant: To be prescribed to adult patients with mild-to-moderate COVID-19 at high risk of severe disease, aged 18 years of age and older, have not used oxygen therapy and have onset within 5 days. For patients who could not use other recommended drugs.
